We are live on
!
Find out more
TC
Tejara Capital Portfolio holdings
AUM
$303M
1-Year Est. Return
5.43%
This Fund
S&P 500
This Quarter
Est. Return
-4.23%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$2.93M
(+1.1%)
Cap. Flow
+$14.7M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
92
New
17
Increased
31
Reduced
13
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$10.5M |
| 2 |
California Resources
CRC
|
+$6.71M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$6.28M |
| 4 |
Pediatrix Medical
MD
|
+$4.99M |
| 5 |
Transocean
RIG
|
+$4.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scorpio Tankers
STNG
|
+$23.2M |
| 2 |
Golar LNG
GLNG
|
+$12M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$5.57M |
| 4 |
Roivant Sciences
ROIV
|
+$4.56M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$3.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.95% |
| 2 | Energy | 28.93% |
| 3 | Industrials | 6.09% |
| 4 | Communication Services | 5.72% |
| 5 | Financials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apple
AAPL
$4.95T
| $1.05M | 0.38% |
+5,000
| New | +$932K |
|
|
BRY
52
DELISTED
Berry Corp
BRY
| $1.04M | 0.38% |
+160,500
| New | +$1.19M |
|
|
PTVE
53
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $704K | 0.26% |
62,233
+33,890
| +120% | +$451K |
|
54
Fluor
FLR
$7.22B
| $653K | 0.24% |
15,000
-35,000
| -70% | -$1.46M |
|
55
TherapeuticsMD
TXMD
$24M
| $647K | 0.24% |
401,937
| – | – |
|
56
Sutro Biopharma
STRO
$398M
| $595K | 0.22% |
20,315
+873
| +4% | +$34.5K |
|
57
Amneal Pharmaceuticals
AMRX
$5.78B
| $551K | 0.2% |
+86,824
| New | +$551K |
|
58
Teladoc Health
TDOC
$1.61B
| $489K | 0.18% |
+50,000
| New | +$610K |
|
|
CMRX
59
DELISTED
Chimerix, Inc.
CMRX
| $363K | 0.13% |
414,430
| – | – |
|
60
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $347K | 0.13% |
400
-1,200
| -75% | -$628K |
|
61
Oportun Financial
OPRT
$262M
| $312K | 0.11% |
107,553
-73,274
| -41% | -$222K |
|
62
Precision BioSciences
DTIL
$187M
| $241K | 0.09% |
24,767
| – | – |
|
63
Sibanye-Stillwater
SBSW
$6.05B
| $229K | 0.08% |
+52,600
| New | +$260K |
|
|
RVNC
64
DELISTED
Revance Therapeutics, Inc.
RVNC
| $213K | 0.08% |
82,688
-87,312
| -51% | -$298K |
|
|
ICD
65
DELISTED
Independence Contract Drilling, Inc.
ICD
| $135K | 0.05% |
103,756
-95,194
| -48% | -$156K |
|
|
RNLX
66
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $116K | 0.04% |
500,394
| – | – |
|
67
Ovid Therapeutics
OVID
$439M
| $52.7K | 0.02% |
68,517
-4,636
| -6% | -$12.9K |
|
|
AXDX
68
DELISTED
Accelerate Diagnostics
AXDX
| $15.9K | 0.01% |
13,614
| – | – |
|
69
AES
AES
$10.6B
| – | – |
-98,800
| Closed | -$1.77M |
|
70
Ardmore Shipping
ASC
$669M
| – | – |
-203,894
| Closed | -$3.35M |
|
71
AtaiBeckley Inc
ATAI
$2.65B
| – | – |
-260,215
| Closed | -$513K |
|
72
Alibaba
BABA
$276B
| – | – |
-13,700
| Closed | -$991K |
|
73
Dole
DOLE
$1.34B
| – | – |
-44,314
| Closed | -$529K |
|
|
74
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
| – | – |
-96,900
| Closed | -$3.75M |
|
75
Genesis Energy
GEL
$1.81B
| – | – |
-184,384
| Closed | -$25.8K |
|
Similar funds
EC
ECAM
BPH
BCC
BKA
SF
AFO
OWM
Tejara Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Tejara Capital held 92 positions worth $275M, up 1.1% from $272M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Tejara Capital deployed $14.7M of net new capital in Q2 2024, opening 17 new positions and adding to 31 existing holdings. Its largest new stake was Global Payments: 95,000 shares worth $9.19M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $5.57M trimmed.
- Tejara Capital's largest Q2 2024 buy was Global Payments: 95,000 shares worth $9.19M.
- Tejara Capital added most to Transocean in Q2 2024, an estimated $4.52M increase.
- Tejara Capital's biggest Q2 2024 reduction was Teva Pharmaceuticals, cutting an estimated $5.57M.
- Tejara Capital fully exited Scorpio Tankers in Q2 2024, selling an estimated $23.2M.
- Tejara Capital's ten largest holdings make up 44% of its $275M portfolio in Q2 2024.
- Tejara Capital opened 17 new positions and closed 24 in Q2 2024.
- Tejara Capital's portfolio value rose 1.1% quarter-over-quarter to $275M.
Based on Tejara Capital's 13F filing for Q2 2024, filed 14 Aug 2024.